Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 mai 2017 16h05 HE | Source: Quotient Limited

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expected in...
09 mai 2017 16h05 HE | Source: Quotient Limited

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
09 mai 2017 08h00 HE | Source: Quotient Limited

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter...
10 avr. 2017 16h05 HE | Source: Quotient Limited

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, April 10, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering of...
05 avr. 2017 09h21 HE | Source: Quotient Limited

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, April 05, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of...
04 avr. 2017 16h01 HE | Source: Quotient Limited

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, April 04, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public...
30 mars 2017 16h50 HE | Source: Quotient Limited

Quotient Reports Continued Positive MosaiQ™ Performance Evaluation Results

Antibody Detection – enhanced detection versus predicate technologiesManufacturing of Microarrays for European field trials planned to commence in early AprilMosaiQ™ instrument development completed...
23 mars 2017 16h05 HE | Source: Quotient Limited

FDA Licenses Eight New Quotient Reagent Products for Sale in the U.S.

Products are rare antisera blood typing reagents developed and manufactured by QuotientU.S. commercialization of these products will extend the range and method of reagents available in the market for...
22 févr. 2017 08h00 HE | Source: Quotient Limited

Quotient Limited to Participate in the Cowen and Company 37th Annual Health Care Conference

JERSEY, Channel Islands, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
09 févr. 2017 16h05 HE | Source: Quotient Limited

Quotient Limited Announces Appointment of Christopher Lindop as Chief Financial Officer

JERSEY, Channel Islands, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Christopher Lindop as Chief...

Page précédente